Biocard selects CRO Starter Kit CTMS by Flex Databases
Flex Databases, a company specialising in clinical trial software, has announced that Biocard has selected Flex CRO Starter Kit as its business automation platform.
With offices in Frankfurt, Germany and local presence across Russia and Belarus, Biocard is a full service CRO with a strong record of fast and high quality recruitment, covering Western, Central and Eastern European countries. Besides clinical trial management, Biocard offers drug import services and bioequivalence study support. Biocard will use CRO Starter Kit to further improve its operational efficiency and solidify its position as a forward looking CRO open to innovative technology.
"The market is changing, and what was sufficient 5 years ago is no longer enough today", said Oleg Baykov, Director of Business Development at Biocard. "The standard of operational efficiency is rising across industries, driven by advances in technology in the business-to-consumer market. Sponsors expect true efficiency and timely flow of reliable information, which is impossible to achieve without Professional Services Automation software, and CRO Starter Kit™ is the only PSA suite for clinical research available on the market. We now have a platform built for small and medium CROs, with highly sought after clinical research tools such as eTMF included in the platform."
"We are delighed to have been selected by Biocard", said Timur Galimov, Technical Director of Flex Databases. "As a company with long history and wealth of experience in clinical research, Biocard were a demanding prospect, and we feel that this deal will serve as additional validation for our business model and platform philosophy which is still ground breaking for the clinical research market."
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance